×
Bayer Total Long-Term Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
Bayer Total Long-Term Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$710.1B
Novo Nordisk (NVO)
$471.5B
Johnson & Johnson (JNJ)
$373.6B
AbbVie (ABBV)
$312.7B
Merck (MRK)
$250.9B
Novartis AG (NVS)
$213.1B
AstraZeneca (AZN)
$203.5B
Pfizer (PFE)
$145.4B
Sanofi (SNY)
$122.5B
Innoviva (INVA)
$1.2B